Why the study?
Does intravenous isoproterenol act as an effective marker of intravascular injection in anesthetized children?
Does intravenous isoproterenol act as an effective marker of intravascular injection in anesthetized children?
Isoproterenol 0.075 microgram/kg produces a reliable heart rate increase in anesthetized children, showing promise as an epidural test dose marker, though further safety evaluation is needed.
Answers are grounded in this paper and cite their sources.
Isoproterenol 0.075 μg/kg reliably marks intravascular injection via heart rate rise in anesthetized children; extends adult data but needs pediatric safety confirmation.
The purpose of this study was to determine if isoproterenol would be an effective marker of intravascular injection in anesthetized children. Forty-four ASA 1 children, aged 2 mo to 10 yr, were randomly assigned to two groups. Children in group 1 (n = 21) received 0.05 microgram/kg isoproterenol, and children in group 2 (n = 23) received 0.075 microgram/kg isoproterenol. A blinded observer continuously recorded heart rate and arterial blood pressure. Measurements were recorded before the surgical incision at steady-state halothane concentration of 1.2 minimum alveolar concentration adjusted for age. Isoproterenol produced a graded increase in heart rate with mean maximum increases of 16.5 +/- 8.7 beats/min in group 1 and 21.5 +/- 9.2 beats/min in group 2. No episodes of hypotension and arrhythmia were noted. Isoproterenol, 0.075 microgram/kg, is more sensitive but still is an imperfect marker of an intravascular injection. It produces a heart rate increase in 96% of children anesthetized with halothane and nitrous oxide in 50% oxygen. The application of isoproterenol as an epidural test dose appears promising, but cannot be recommended until its full reliability and neurotoxicity are evaluated.
No takes yet. Share an insight, caveat, or question.
Perillo et al. (1993) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: